Paolo Luraghi
Milan, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Treatment Pathway and Clinical Outcomes of the Population with Muscle-invasive Bladder Cancer in Italy: A Real-world Analysis with Administrative Databases.
Journal: Advances in therapy
Published: July 17, 2025
Real-World Treatment Patterns and Overall Survival (OS) of Patients with Metastatic Castration-Resistant Prostate Cancer in Italy.
Journal: Pragmatic and observational research
Published: May 08, 2025
MicroRNA 483-3p overexpression unleashes invasive growth of metastatic colorectal cancer via NDRG1 downregulation and ensuing activation of the ERBB3/AKT axis.
Journal: Molecular oncology
Published: November 04, 2022
Temozolomide Treatment Alters Mismatch Repair and Boosts Mutational Burden in Tumor and Blood of Colorectal Cancer Patients.
Journal: Cancer discovery
Published: November 01, 2021
Colorectal cancer residual disease at maximal response to EGFR blockade displays a druggable Paneth cell-like phenotype.
Journal: Science translational medicine
Published: April 26, 2019
A Molecularly Annotated Model of Patient-Derived Colon Cancer Stem-Like Cells to Assess Genetic and Nongenetic Mechanisms of Resistance to Anti-EGFR Therapy.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 27, 2017
MET inhibition overcomes radiation resistance of glioblastoma stem-like cells.
Journal: EMBO molecular medicine
Published: May 04, 2016
Lenalidomide normalizes tumor vessels in colorectal cancer improving chemotherapy activity.
Journal: Journal of translational medicine
Published: July 09, 2015
MET-mediated resistance to EGFR inhibitors: an old liaison rooted in colorectal cancer stem cells.
Journal: Cancer research
Published: July 03, 2014
MET signaling in colon cancer stem-like cells blunts the therapeutic response to EGFR inhibitors.
Journal: Cancer research
Published: January 23, 2014
The MET oncogene is a functional marker of a glioblastoma stem cell subtype.
Journal: Cancer research
Published: June 29, 2012
Last Updated: 09/26/2026